Dinesh Ramniranjan Jain

Dinesh Ramniranjan Jain

Active Director Director DIN 00058069
DIN 00058069 First appointment Mar 2002 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 15 historical roles
Total affiliations 20 Since Mar 2002
Shareholding value Locked Premium profile

About Dinesh Ramniranjan Jain

Dinesh Ramniranjan Jain has 24 years in corporate governance. Holds Director role. Currently with 5 companies, including Meditab Specialities Limited and Cipla Life Sciences Private Limited. Formerly with 15 companies, such as Goldencross Pharma Limited and Cipla Global Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.

DIN 00058069
Primary Designation Director
First Appointment 28 Mar 2002
Oldest Company Age 34 yrs

Current companies

Company Designation Appointment Founded Status
Meditab Specialities Limited U23240MH1996PLC104442
Director 03 Jan 2019 1996 Active
Cipla Pharmaceuticals Limited U24239MH2019PLC333266
Director 19 Nov 2019 2019 Active
Jay Precision Pharmaceuticals Private Limited U33111MH2012PTC234037
Director 01 Apr 2022 2012 Active
Medispray Laboratories Private Limited U52311GA1992PTC002801
Director 14 Nov 2019 1992 Active
Cipla Digital Health Limited U72900MH2022PLC377512
Director 25 Feb 2022 2022 Active

Previous companies

Company Designation Appointment Founded Status
Goldencross Pharma Limited U24239MH2000PLC123766
Director 14 Nov 2019 2000 Active
Cipla Global Limited U24100MH2008PLC187824
Director 29 Oct 2008 2008 Strike Off
Forest Gold Products Private Limited U24230MH2000PTC125771
Director 18 Sep 2002 2000 Active
Four M Propack Private Limited U51900MP2008PTC049194
Director 21 Aug 2008 2008 Active
Nebumed Pharma Private Limited U24230MH2000PTC125579
Director 28 Mar 2002 2000 Converted To Llp
One World Pharma Private Limited U24239MH2000PTC130017
Director 19 Dec 2002 2000 Converted To Llp
Medule Pharma Private Limited U24230MH2000PTC125851
Director 28 Mar 2002 2000 Converted To Llp
Medlar Laboratories Private Limited U73100MH1997PTC107710
Director 05 Jun 2004 1997 Strike Off
Cipla Life Sciences Private Limited U24230MH2000PTC125770
Director 18 Sep 2002 2000 Strike Off
Four M Pharmaceuticals Private Limited U24239MH2008PTC184410
Director 08 Jul 2008 2008 Strike Off
Eternal Energy Systems Private Limited U40101MH2010PTC198915
Director 14 Jan 2010 2010 Strike Off
Okasa Laboratories Private Limited U73100MH2000PTC129591
Director 04 Nov 2011 2000 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Meditab Specialities Limited
Cipla Life Sciences Private Limited
Four M Pharmaceuticals Private Limited
Cipla Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Dinesh Ramniranjan Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dinesh Ramniranjan Jain

Dinesh Ramniranjan Jain has 24 years in corporate governance. Holds Director role. Currently with 5 companies, including Meditab Specialities Limited and Cipla Life Sciences Private Limited. Formerly with 15 companies, such as Goldencross Pharma Limited and Cipla Global Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.

Dinesh Ramniranjan Jain is associated with 5 companies as Director.

Dinesh Ramniranjan Jain has expertise in General Business, Healthcare.

Dinesh Ramniranjan Jain has 24 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available